𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recurrence and variability of germline EPCAM deletions in Lynch syndrome

✍ Scribed by Roland P. Kuiper; Lisenka E.L.M. Vissers; Ramprasath Venkatachalam; Danielle Bodmer; Eveline Hoenselaar; Monique Goossens; Aline Haufe; Eveline Kamping; Renée C. Niessen; Frans B.L. Hogervorst; Johan J.P. Gille; Bert Redeker; Carli M.J. Tops; Marielle E. van Gijn; Ans M.W. van den Ouweland; Nils Rahner; Verena Steinke; Philip Kahl; Elke Holinski-Feder; Monika Morak; Matthias Kloor; Susanne Stemmler; Beate Betz; Pierre Hutter; David J. Bunyan; Sapna Syngal; Julie O. Culver; Tracy Graham; Tsun L. Chan; Iris D. Nagtegaal; J. Han J.M van Krieken; Hans K. Schackert; Nicoline Hoogerbrugge; Ad Geurts van Kessel; Marjolijn J.L. Ligtenberg


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
335 KB
Volume
32
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Recently, we identified 3' end deletions in the EPCAM gene as a novel cause of Lynch syndrome. These truncating EPCAM deletions cause allele-specific epigenetic silencing of the neighboring DNA mismatch repair gene MSH2 in tissues expressing EPCAM. Here we screened a cohort of unexplained Lynch-like families for the presence of EPCAM deletions. We identified 27 novel independent MSH2-deficient families from multiple geographical origins with varying deletions all encompassing the 3' end of EPCAM, but leaving the MSH2 gene intact. Within The Netherlands and Germany, EPCAM deletions appeared to represent at least 2.8% and 1.1% of the confirmed Lynch syndrome families, respectively. MSH2 promoter methylation was observed in epithelial tissues of all deletion carriers tested, thus confirming silencing of MSH2 as the causative defect. In a total of 45 families, 19 different deletions were found, all including the last two exons and the transcription termination signal of EPCAM. All deletions appeared to originate from Alu-repeat mediated recombination events. In 17 cases regions of microhomology around the breakpoints were found, suggesting nonallelic homologous recombination as the most likely mechanism. We conclude that 3' end EPCAM deletions are a recurrent cause of Lynch syndrome, which should be implemented in routine Lynch syndrome diagnostics.


📜 SIMILAR VOLUMES


Germline hypermethylation of MLH1 and EP
✍ Renée C. Niessen; Robert M. W. Hofstra; Helga Westers; Marjolijn J. L. Ligtenber 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

## Abstract It was shown that Lynch syndrome can be caused by germline hypermethylation of the __MLH1__ and __MSH2__ promoters. Furthermore, it has been demonstrated very recently that germline deletions of the 3′ region of __EPCAM__ cause transcriptional read‐through which results in silencing of

High frequency of exon deletions and put
✍ George Chong; Jonathan Jarry; Victoria Marcus; Isabelle Thiffault; Sebastian Win 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

Lynch syndrome is one of the most common autosomal dominantly inherited cancer syndromes. Mutations in MLH1, MSH2, MSH6, and PMS2 account for greater than 98% of reported mutations in Lynch syndrome families. It has been reported that large genomic deletions in MLH1 and MSH2 are a frequent cause of

Distinct patterns of germ-line deletions
✍ Lili Li; Susan McVety; Rami Younan; Ping Liang; Desirée Du Sart; Philip H. Gordo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

A relatively high frequency of germ-line genomic rearrangements in MLH1 and MSH2 has been reported among Lynch Syndrome (HNPCC) patients from different ethnic populations. To investigate the underlying molecular mechanisms, we characterized the DNA breakpoints of 11 germ-line deletions, six for MLH1

Allelic imbalance, including deletion of
✍ Debbie J. Marsh; Patricia L. M. Dahia; Valérie Coulon; Zimu Zheng; Françoise Dor 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 3 views

Cowden disease (CD) is a rare, autosomal dominant inherited cancer syndrome characterized by multiple benign and malignant lesions in a wide spectrum of tissues. While individuals with CD have an increased risk of breast and thyroid neoplasms, the primary features of CD are hamartomas. The gene for